Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Pain, Postoperative 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

Bupivacaine 8Control Groups 6Saline Solution 5Ropivacaine 5Ketamine 5Sodium Chloride 4Lidocaine 4Dexmedetomidine 4Anesthetics, Local 4Morphine 3Anti-Inflammatory Agents, Non-Steroidal 3Diazepam 2Botulinum Toxins, Type A 2Analgesics, Opioid 2Acetaminophen 2thiamine triphosphorate 1oxycodone-acetaminophen 1esmolol 1Vitamins 1Tramadol 1Therapeutics 1Surgical Procedures, Operative 1Sufentanil 1Nerve Block 1Narcotics 1Nalbuphine 1Mindfulness 1Mastectomy, Segmental 1Mammaplasty 1Magnesium Sulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain, Postoperative × Sufentanil × Breast × Clear all
NCT04248179 2023-02-09

The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.

Zealand University Hospital

Phase 4 Completed
36 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡